Beijing Gegen biotechnology co., LTD. is a CRO and new drugs R&D company, specializes in the development of antibodies based on phage display technology. The company products are widely used in the diagnosis and therapy of tumors, allergies, autoimmune diseases, cardiovascular diseases, bacterial or viral infections and other diseases. Gegen offers its customers with complete scientific research and technical solutions, including experiment design and implementation, data analysis, and project consultation services. Gegen has established cooperative relationships with many domestic pharmaceutical companies, hospitals and scientific research organizations, by providing long-term technical services.
Gegen adheres to the concept of "taking experiments as the basis and striving for excellence". The company has established several advanced biomedical technology service platforms and a professional technical service team. More than 70% of the company employees have a master's degree or above and have much experience in antibody development. Furthermore, the company has invited several outstanding biomedical scientists at home and abroad as scientific advisers. The aim of the company is to provide excellent technical services to its customers. The company will help customers to reduce research cost, shorten research run term, and comprehensively improve research level. Through providing both CRO and CMO services, the company is committed to using advanced biological technology to help its customs to improve the research level and production effectiveness.
贵州福彩网At the same time, Gegen is also committed to the development of innovative biological drugs based on small molecular antibodies. Intact antibodies are not suitable drugs for in vivo application because of their large size. The high therapy cost of intact antibody drugs is also limited their widely usage. Small molecular antibodies, on the other hand, are easy to absorption, and have good efficacy, low immunogenicity and relatively lower production cost. With these characteristics, small molecular antibodies will inevitably become attractive alternatives in diagnosis and therapy field.
Nanoantibodies are emerging small antibody molecules with unique bioactivities. Based on its abundant resources in the Inner Mongolia region, Gegen has established an intact nanoantibody service system involving camel and South American camelid breeding, immunization, blood collection, antibody library construction and screening. Gegen is dedicated to producing quality nanoantibodies for both clients and itself.